Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Vivos Therapeutics Inc | VVOS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.46 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.37 - 48.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 2.46 | USD |
Vivos Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.95M | 1.20M | - | 13.8M | -13.58M | -11.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vivos Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VVOS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.69 | 2.7399 | 2.37 | 2.59 | 46,806 | -0.23 | -8.55% |
1 Month | 3.75 | 3.9899 | 2.37 | 2.82 | 405,090 | -1.29 | -34.40% |
3 Months | 6.30 | 6.60 | 2.37 | 3.59 | 197,589 | -3.84 | -60.95% |
6 Months | 7.05 | 48.79 | 2.37 | 28.82 | 631,550 | -4.59 | -65.11% |
1 Year | 9.105 | 48.79 | 2.37 | 11.50 | 1,900,962 | -6.65 | -72.98% |
3 Years | 191.25 | 200.00 | 2.37 | 50.90 | 1,374,476 | -188.79 | -98.71% |
5 Years | 176.75 | 360.25 | 2.37 | 56.75 | 1,270,959 | -174.29 | -98.61% |
Vivos Therapeutics Description
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. |